With Latest FDA 510(k), physIQ Achieves Another Clearance as a Pioneer in AI Analytics

CHICAGO–(BUSINESS WIRE)–PhysIQ, a leader in applying AI analytics to biosensor data, today announced it has received FDA 510(k) clearance for its Atrial Fibrillation (AFib) detection analytics engine. The clearance extends physIQ’s portfolio of FDA 510(k) cleared analytics designed to generate clinical insight from wearable biosensors and further establishes physIQ as a global leader in developing, validating, and commercializing AI-based physiology analytics. The newly cleared analytic is available within the pinpointIQ® solution for patient care delivery as well as the company’s accelerateIQ® platform for clinical trials.